In Brief: Nellcor
This article was originally published in The Gray Sheet
Executive Summary
Nellcor: Expects U.S. shipments to begin immediately for the first two modules of its Symphony monitoring system -- the N-3000 pulse oximeter and the N-3100 non-invasive blood pressure monitor. The market release of both products follows FDA clearance last week of a 510(k) for the N-3000. The N-3100 was cleared in March. Sales of the Symphony system, introduced internationally in 1994, will focus on noncritical hospital and alternate site markets...